Stocktoria

IDEXX LABORATORIES INC /DE IDXX

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-06-21

IDEXX LABORATORIES INC /DE statistics & valuation

Market cap$43.5B
P / E41.1×
P / S10.1×
P / B27.1×
P / FCF41.2×
Net margin24.6%
Return on equity66.0%
FCF margin24.6%
Net debt$269.9M
Net debt / EBITDA0.2×
Enterprise value USD$43.8B
EV / EBITDA29.1×
Earnings yield EBIT/EV3.1%
Return on capital61.8%
Graham number -86.6%$76.36

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($76.36); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
12.50% 13.40% 17.00% 17.80% 21.50% 23.20% 20.20% 23.10% 22.80% 24.60% 2016201720182019202020212022202320242025
Gross margin (%)
54.90% 55.70% 56.10% 56.70% 58.00% 58.80% 59.50% 59.80% 61.00% 61.80% 2016201720182019202020212022202320242025
Operating margin (%)
19.70% 21.00% 22.20% 23.00% 25.70% 29.00% 26.70% 30.00% 29.00% 31.60% 2016201720182019202020212022202320242025
Return on equity (%)
240.50% 91.90% 107.90% 111.60% 56.90% 55.70% 66.00% 2016201720182019202020212022202320242025
Shares outstanding
90.9M 89.6M 88.5M 87.5M 86.7M 86.6M 84.6M 84.0M 83.2M 81.0M 2016201720182019202020212022202320242025
Net debt ($)
$438.8M $418.9M $478.0M $609.1M $525.2M $706.3M $657.2M $244.3M $329.5M $269.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
14.50% 15.40% 24.50% 23.30% 25.40% 30.60% 24.70% 25.90% 27.00% 31.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
15.40% 15.20% 12.80% 12.60% 20.00% 19.80% 11.70% 21.10% 20.70% 24.60% 2016201720182019202020212022202320242025
Debt / equity (×)
3.93× 1.44× 1.23× 1.26× 0.47× 0.39× 0.28× 2016201720182019202020212022202320242025
EPS ($)
$2.44 $2.94 $4.26 $4.89 $6.71 $8.60 $8.03 $10.06 $10.67 $13.08 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

IDEXX LABORATORIES INC /DE trades at about 43.6× earnings — below its 10-year norm (10-year range 39.6×–71.3×, median 55.4×).

39.6× 71.3×

Shaded band = 10-year range (39.6×–71.3×); dot = today's 43.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin61.8%61.0%59.8%59.5%58.8%58.0%56.7%56.1%55.7%54.9%
Operating margin31.6%29.0%30.0%26.7%29.0%25.7%23.0%22.2%21.0%19.7%
Net margin24.6%22.8%23.1%20.2%23.2%21.5%17.8%17.0%13.4%12.5%
FCF margin24.6%20.7%21.1%11.7%19.8%20.0%12.6%12.8%15.2%15.4%
Return on assets31.6%27.0%25.9%24.7%30.6%25.4%23.3%24.5%15.4%14.5%
Return on equity66.0%55.7%56.9%111.6%107.9%91.9%240.5%-3963.3%-486.3%-204.9%
Debt / equity0.28×0.39×0.47×1.26×1.23×1.44×3.93×-63.26×-11.21×-5.48×
Current ratio1.231.311.570.891.251.820.940.850.970.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.